Repaglinide Tablet
Product Images NDC 72162-2558

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Repaglinide (NDC 72162-2558). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622558)

Label for Repaglinide Tablets USP 1 mg, oral tablets relabeled by Bryant Ranch Prepack, Inc. The label states package size as 100 tablets and includes storage instructions to keep at 20° to 25°C and protect from moisture. It also shows manufacturing by Aurobindo Pharma Limited with NDC 72162-2558-1 and contains QR codes for package insert and prescribing information.*

FDA Label Image

Figure 1: Repaglinide In Combination With Pioglitazone: Hba1c Values (Repaglinide Fig1)

A line graph showing the change in HbA1c (%) over 24 treatment weeks for three groups: Repaglinide plus Pioglitazone, Repaglinide alone, and Pioglitazone alone. The x-axis represents treatment weeks (0 to 24) and the y-axis represents percentage change in HbA1c, with the combination treatment showing the greatest reduction.*

FDA Label Image

Chemical Structure (Repaglinide Str)

Chemical structure of Repaglinide shown as a 2D molecular diagram depicting its chemical bonds and molecular groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.